The groundbreaking treatment of this peptide represents a major advance in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment